FONSVILA-REAL, FI

Leaves the portfolio; it was 9.09% of weight.

Leaves the portfolio; it was 9.09% of weight.

Leaves the portfolio; it was 9.08% of weight.

Leaves the portfolio; it was 2.05% of weight.

Leaves the portfolio; it was 0.91% of weight.

Leaves the portfolio; it was 0.83% of weight.

Leaves the portfolio; it was 0.80% of weight.

Imerys S.A. engages in the supply of specialty minerals for various industries across Europe, the Middle East, Africa, Asia Pacific, and America. The company offers performance minerals, such as additives for plastics, paints and coatings, filtration and life sciences, ceramics, and building products; specialty minerals used as processing aids for extreme work conditions, including refractory, foundry, abrasives, and building chemistry; and graphite and carbon minerals for energy transition and mobile energy markets. It also provides minerals, such as andalusite, ball clay, bentonite, calcium carbonate, carbon black, chamotte, diatomite, feldspar, fused alumina, graphite, halloysite, kaolin, lithium, mica, moler, mullite, perlite, quartz, talc, zeolite, zirconia, and wollastonite. The company serves various markets, such as abrasives, advanced ceramics, animal care, batteries and fuel cells, building materials, ceramics, component manufacturing, cosmetics and personal care, crop production, food and beverage, health, pharmaceuticals and biotechnology, home care, infrastructure and utilities, investment casting, pulp and packaging, and rubber markets. The company was incorporated in 1880 and is headquartered in Paris, France. Imerys S.A. is a subsidiary of Belgian Securities BV.

Leaves the portfolio; it was 0.77% of weight.

Leaves the portfolio; it was 0.75% of weight.

Leaves the portfolio; it was 0.70% of weight.

Leaves the portfolio; it was 0.69% of weight.

Leaves the portfolio; it was 0.68% of weight.

Leaves the portfolio; it was 0.64% of weight.

Prosegur Compañía de Seguridad, S.A. operates in the private security sector. It operates through Security, Cash, Alarms, Cybersecurity, and AVOS (added-value outsourcing services) segments. The Security segment engages in guarding and protection of premises, goods and individuals, and activities related to technological security solutions. The Cash segment is involved in the transportation, storage, safekeeping, counting, and classification of coins and bank notes, deeds, securities, and other items that require special protection due to their economic value or risk; international payment services, online foreign currency, travel money home delivery, and local cash services; and correspondent banking and auxiliary payment services, inter alia, receipt and payment management, and bill payment services. The Alarms segment engages in the installation and maintenance of home alarm systems, as well as the provision of alarm monitoring services. The Cybersecurity segment provides managed detection and response, managed security, cyber intelligence, readteam, management, and risk and compliance services; integration of cybersecurity technology; automation of processes for early detecting cyber-attacks on enterprises; and response and protection through the xMDR solution. The AVOS segment offers business process outsourcing services to enhance operational management through redesign, automation, and digital transformation in financial and insurance companies. It operates in Germany, Argentina, Australia, Austria, Brazil, Chile, China, Colombia, Costa Rica, Cyprus, Denmark, Ecuador, El Salvador, Spain, the United States, the Philippines, Finland, France, Guatemala, Honduras, Iceland, India, Indonesia, Italy, Mexico, Nicaragua, New Zealand, Paraguay, Peru, Portugal, the United Kingdom, Singapore, South Africa, Sweden, and Uruguay. The company was incorporated in 1976 and is based in Madrid, Spain. Prosegur Compañía de Seguridad, S.A. operates as a subsidiary of Gubel, S.L.

Leaves the portfolio; it was 0.63% of weight.

ABN AMRO Bank N.V. provides various banking products and financial services to retail, private, and corporate banking clients in the Netherlands, rest of Europe, the United States, Asia, and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company offers fixed deposits; home improvement; mortgage products; investment products; and car, home travel, and legal expenses insurances. It also provides pension savings; asset-based solutions, including working capital solutions, equipment leases, equipment loans and vendor lease services, clearing services, equity brokerage services, payment and credit cards services; and internet and online banking. The company was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands. ABN AMRO Bank N.V. operates as a subsidiary of Stichting Administratiekantoor Continuïteit Abn Amro Bank.

Leaves the portfolio; it was 0.62% of weight.

Leaves the portfolio; it was 0.60% of weight.

Leaves the portfolio; it was 0.58% of weight.

Leaves the portfolio; it was 0.55% of weight.

Leaves the portfolio; it was 0.53% of weight.

Leaves the portfolio; it was 0.52% of weight.

Leaves the portfolio; it was 0.52% of weight.

Leaves the portfolio; it was 0.52% of weight.

Leaves the portfolio; it was 0.51% of weight.

Airbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aeronautics and aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, markets, and sells civil and military helicopters; and provides uncrewed aerial systems and their related services. The Airbus Defence and Space segment designs, develops, delivers, and supports crewed and uncrewed military air systems and related services. This segment also offers civil and defence space systems for telecommunications, earth observations, navigation, and science and orbital systems; and services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. The company was incorporated in 1998 and is headquartered in Leiden, the Netherlands.

Leaves the portfolio; it was 0.50% of weight.

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers, hospitals, and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Leaves the portfolio; it was 0.49% of weight.

Leaves the portfolio; it was 0.49% of weight.

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary system and sex hormones, immunostimulants, metabolism, musculo-skeletal system, nervous system, respiratory system, systemic hormonal preparations. It also develops tirbanibulin for actinic keratosis, and tildrakizumab for psoriatic arthritis under the registration phase, as well as lebrikizumab for atopic dermatitis pediatric in phase 2; Anti-IL-1RAP mAb for hidradenitis suppurativa, anti-IL-1RAP mAb for inflammatory skin disease, Anti-IL-21 mAb for hidradenitis suppurativa, IL-2muFc for alopecia areata, IL-2muFc for atopic dermatitis, and IL-2muFc for inflammatory skin disease in phase 2; readthrough inducer for rare dermatology in phase 1; and anti-IL-13/OX40L BsAb for atopic dermatitis, SMOL oral for Th2-driven diseases, and mRNA/LNP for non-melanoma skin cancer in preclinical stage. It has research and development agreements with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk, and Eloxx. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Leaves the portfolio; it was 0.48% of weight.

Azimut Holding S.p.A. provides asset management and advisory solutions in Italy, Europe, the Middle East, the Americas, and the Asia-Pacific. It offers public and private markets, discretionary portfolio management, and token and digital asset solutions; advisory services; corporate investment banking and fintech solutions; mutual funds harmonized with the UCITS directive; alternative investment funds and open pension funds; and individual management of investment portfolios on behalf of third parties. The company also provides private insurance, unit linked insurance plans, and optional coverage; and pensions for individuals and companies. Azimut Holding S.p.A. was incorporated in 1990 and is headquartered in Milan, Italy.

Leaves the portfolio; it was 0.48% of weight.

Leaves the portfolio; it was 0.48% of weight.

Leaves the portfolio; it was 0.47% of weight.

Leaves the portfolio; it was 0.47% of weight.

Leaves the portfolio; it was 0.46% of weight.

Leaves the portfolio; it was 0.45% of weight.

Ebro Foods, S.A. operates as a food company in Spain, the Americas, Europe, and internationally. The company offers dry, fresh, frozen, organic, aromatic, and brown rice; premium, fresh, and filled pasta; ready-to-serve rice and pasta dishes; sauces; flours and ingredients; and canned vegetables. It sells its products under the Brillante, SOS, La Fallera, Santa Rita, La Cigala, Rocio, Santa Lucia, Arotz, Garofalo, Cigala, Bertagni, Russo, Ris-Fix, Königs Reis, Lustucru, Lassie, Tilda, Taureau Ailé, Boss, Oryza, Saludães, Mahatma, Riceland, Bosto, Adolphus, Minute, Reis-Fit, Gourmet House, Success, Risella, Herba, Blue Ribbon Rice, Casi, Pear Blossom, Rice Select, Carolina, Water Maid, River, AA, Ultimate, Wonder, Comet Rice, Peacock, Minute Rice, Colusa Rose, Kohinoor, Olivieri, Sello Rojo, In Harvest, Puroma, Miura, Abu Bint, Rix fis, and Phoenix brands. The company also engages in insurance and finance; administration; farmland concessionaire; rice farming; logistics; and investment management activities. It exports its products. The company was formerly known as Ebro Puleva, S.A. and changed its name to Ebro Foods, S.A. in June 2010. Ebro Foods, S.A. was incorporated in 1998 and is headquartered in Madrid, Spain.

Leaves the portfolio; it was 0.41% of weight.

Leaves the portfolio; it was 0.40% of weight.

Leaves the portfolio; it was 0.39% of weight.

Renault SA engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in Europe, Eurasia, Africa, the Middle East, the Asia Pacific, and the Americas. The company operates through Automotive, Sales Financing, and Mobility Services segments. The Automotive segment produces, sells, and distributes passenger cars and light commercial vehicles. The Sale Financing segment is involved in the sales financing, rental, maintenance, and service contracts under the Mobilize Financial Services trade name. The Mobility Services segment provides mobility and energy solutions for electric vehicle users under the Mobilize Beyond Automotive brand. It offers used vehicles and spare parts; and engages in the business-to-business powertrain activities, and research and advanced engineering activities. The company also engages in the design and production of parts and equipment used for manufacturing and operation of vehicles. It serves commercial, light commercial and passenger vehicles, tractors, farm machinery and construction equipment under the Renault, Dacia, and Alpine brands. The company was founded in 1898 and is based in Boulogne-Billancourt, France.

Leaves the portfolio; it was 0.39% of weight.

Leaves the portfolio; it was 0.39% of weight.

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Leaves the portfolio; it was 0.38% of weight.

Leaves the portfolio; it was 0.38% of weight.

Leaves the portfolio; it was 0.35% of weight.

Leaves the portfolio; it was 0.35% of weight.

Leaves the portfolio; it was 0.32% of weight.

Leaves the portfolio; it was 0.28% of weight.

Leaves the portfolio; it was 0.09% of weight.

Leaves the portfolio; it was 0.01% of weight.

Leaves the portfolio; it was 0.00% of weight.